We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1830:TADAWULLeejam Sports Company Analysis

Data as of 2026-06-18 - not real-time

SAR 81.05

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Leejam Sports is trading at SAR 81.05, just below its 20‑day SMA (≈ 81.68) and well under the 50‑day (≈ 82.88) and 200‑day (≈ 104.86) averages, signaling a short‑term bearish bias. The RSI sits near 45, indicating limited upside momentum, while the MACD histogram is modestly positive and the MACD line sits above its signal, offering a faint bullish hint that could spark a brief bounce. Current price hovers just above the identified support at SAR 80.30 and below the near‑term resistance of SAR 84.90, with volume trending upward, suggesting any move above resistance may be volume‑driven. Fundamentally, revenue growth is flat (≈ 0%), but operating margins remain healthy at roughly 21% and profit margins near 18%. The company carries a heavy debt load (debt‑to‑equity ≈ 177) and a payout ratio above 60%, raising concerns about dividend sustainability despite a 2.8% yield. With a discounted cash‑flow fair value of about SAR 48, the market price implies a substantial overvaluation, and the forward EPS outlook (≈ 9.84) offers limited upside to justify the current premium.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Price below key moving averages and near support
  • Overvaluation relative to DCF fair value
  • High leverage amplifying downside risk

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Attractive dividend yield but sustainability concerns
  • Potential upside if market corrects valuation gap
  • Improving forward earnings expectations

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Consumer‑cyclical exposure to Saudi/UAE leisure market
  • Persistent high debt limiting growth flexibility
  • Valuation risk remains elevated despite modest earnings growth

Key Metrics & Analysis

Financial Health

Revenue Growth0.10%
Profit Margin17.51%
P/E Ratio14.9
ROE23.38%
ROA6.61%
Debt/Equity177.19
P/B Ratio3.7
Op. Cash FlowSAR823.0M
Free Cash FlowSAR330.0M

Technical Analysis

TrendBearish
RSI44.8
SupportSAR 80.30
ResistanceSAR 84.90
MA 20SAR 81.68
MA 50SAR 82.88
MA 200SAR 104.86
MACDBullish
VolumeIncreasing
Fear & Greed Index90.8

Valuation

Fair ValueSAR 48.11
Target PriceSAR 111.59
Upside/Downside37.68%
GradeOvervalued
TypeBlend
Dividend Yield2.83%

Risk Assessment

Beta-0.10
Volatility16.69%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.